search
for
 About Bioline  All Journals  Testimonials  Membership  News


Revista Científica UDO Agrícola
Universidad de Oriente Press
ISSN: 1317-9152
Vol. 9, No. 3, 2009, pp. 700-704
Bioline Code: cg09084
Full paper language: English
Document type: Research Article
Document available free of charge

Revista Científica UDO Agrícola, Vol. 9, No. 3, 2009, pp. 700-704

 es Comparación de la actividad antibacterial de diferentes marcas de Ciprofloxacina
Nazir Mughal, Muhammad Shahid; Asghar, Muhammad Tahir; Zia, Muhammad Atif & Ismail, Tariq

Resumen

El presente estudio se realizó para evaluar y comparar la susceptibilidad antibacterial de las bacterias Gram-positiva y Gram-negativa al Cyrocin (Ciprofloxacina). Se usaron las cepas bacetriales Staphyloccocus aureus [ATCC 25923], Escherichia coli [ATCC 25922] y Pseudomonas aeruginosae [ATCC 27853]. Se utilizaron discos comerciales estandars de potencia definida como estandar de referencia (Ciprofloxacin 5μg [CTO425B - OXOID Ltd. UK]). Los productos evaluadoes fueron tabletas de 250 mg y 500 mg de las siguientes marcas: Cyrocin (Highnoon Laboratories Limited), Ciproxin (Bayer Pharma (Pvt) Ltd. - Pakistan), Mercip (Merck Marker (Pvt.) Ltd., Pakistan) y Axcin (Sandoz - Norvatis Pharma Ltd., Pakistan). Los medios usados fueron: Nutrient Broth (Cat. No. 1.05443, Merck, Germany) and Mueller Hinton Agar [Oxoid]. El estudio mostró diferencias estadísticamente no significativas en los resultados de las diferentes marcas,

Palabras-clave
Propiedades antibacteriales, Staphyloccocus aureus, Escherichia coli, Pseudomonas aeruginosae, Ciprofloxacina

 
 en Comparison of the antibacterial activities of different brands of Ciprofloxacin
Nazir Mughal, Muhammad Shahid; Asghar, Muhammad Tahir; Zia, Muhammad Atif & Ismail, Tariq

Abstract

The present study was carried out to evaluate and compare the antibacterial susceptibility of Gram-positive and Gram-negative bacteria to Cyrocin (Ciprofloxacin). The following three bacterial strains were used: Staphyloccocus aureus [ATCC 25923], Escherichia coli [ATCC 25922] and Pseudomonas aeruginosae [ATCC 27853]. Standard commercial discs of definite potency are used as reference standard (Ciprofloxacin 5μg [CTO425B - OXOID Ltd. UK]). The test products were 250 mg and 500 mg tablets of the following brands: Cyrocin (Highnoon Laboratories Limited), Ciproxin (Bayer Pharma (Pvt) Ltd. - Pakistan), Mercip (Merck Marker (Pvt.) Ltd., Pakistan) and Axcin (Sandoz - Norvatis Pharma Ltd., Pakistan). The media used were: Nutrient Broth (Cat. No. 1.05443, Merck, Germany) and Mueller Hinton Agar [Oxoid]. The study showed no statistically significant difference in the results of different brands.

Keywords
Antibacterial properties, Staphyloccocus aureus, Escherichia coli, Pseudomonas aeruginosae, Ciprofloxacin

 
© Copyright 2009 - Revista Científica UDO Agrícola
Alternative site location: http://www.udoagricola.orgfree.com

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil